Molecular Integration of CNS Neurodegenerative Dementias - PowerPoint PPT Presentation

1 / 26
About This Presentation
Title:

Molecular Integration of CNS Neurodegenerative Dementias

Description:

Molecular Integration of CNS Neurodegenerative Dementias. Christine Van Broeckhoven. VIB8 - Department of Molecular Genetics. IBB Laboratory of Neurogenetics ... – PowerPoint PPT presentation

Number of Views:87
Avg rating:3.0/5.0
Slides: 27
Provided by: christinev9
Category:

less

Transcript and Presenter's Notes

Title: Molecular Integration of CNS Neurodegenerative Dementias


1
Molecular Integration of CNS Neurodegenerative
Dementias
  • Christine Van Broeckhoven
  • VIB8 - Department of Molecular Genetics
  • IBB Laboratory of Neurogenetics
  • Neurodegenerative Brain Diseases Group
  • University of Antwerp
  • Belgium

2
Neurodegenerative Brain Diseases
  • Alzheimers Disease (AD)
  • Vascular Dementia (VaD)
  • Lewy Body Dementia (LBD)- Parkinsons Disease
    (PD) with Dementia
  • Frontotemporal Dementia (FTD)
  • Others e. g. Creutzfeldt-Jakob disease (CJD),
    Huntingtons disease (HD)

3
Abnormal Protein Aggregates
Neurofibrillary tangles
Senile plaques
Lewy Bodies
PrPSc plaques
Neurodegeneration
Pick Bodies
Nuclear polyglu inclusions
4
Cerebral Proteopathies
5
Synuclein a
PD
LBD
Tau
Amyloid ß
CAA
6
A Spectrum of Neurodegenerative Disorders ?
Amyloid
Tau
Alzheimers disease
Congophilic Amyloid Angiopathy
Frontotemporal dementia
7
Multifactorial Diseases
molecular genetics
genetic epidemiology
epidemiology
Number of patients
environment
genetic
genetic environment
Genetic
Environment
Early-onset
Late-onset
8
Autosomal Dominant Dementias
9
Prote(in)opathy cascade
mutation
beta-sheet
aggregation
protein
misfolded protein
deposition
Neurodegeneration
10
Cerebral Prote(in)opathies
  • Disorders are clinically and genetically
    heterogeneous
  • Biochemical level Abnormal conformation and
    assembly of proteins
  • Increasing understanding of the process whereby
    proteins self-assemble and injure tissues
  • But the fundamental origin still remains largely
    unknown

11
Alzheimers dementia The Paradigm Proteopathy
Tangle
Plaque
Tangle
Silver stain
Congo red stain
12
Genetics of AD
  • Early-onset AD 1
  • Positive family history in 60, of which 10 with
    autosomal dominant inheritance
  • Mutations in APP, PS1 and PS2
  • Overall 5
  • Familial 10
  • Autosomal dominant 20
  • Classical Alzheimer pathology
  • Amyloid plaques and tau tangles
  • APOE4 increases risk for AD,
  • and decreases onset age

13
Gandy, J Clin Invest, 2005
14
Mutations in AD
  • Majority of the mutations are missense mutations
  • Most mutations are in PS1 (78)
  • Mutations in APP are located at secretase
    cleavage sites
  • Mutations in PSs are distributed over the
    protein
  • Mutations affect APP processing
  • Increased ratio of Aß42/Aß40

15
APP Duplication in AD
  • Genomic APP tandem duplication
  • (Rovelet-Lecrux et al., 2006)
  • 5/65 autosomal dominant AD families ( 8 )
  • 5 different breakpoints
  • APP and several surrounding genes

16
Dutch APP Duplication Family
Interphase FISH
Trisomy 21
APP probe
Reference probe Ch 21
1104
1104
FISH of mechanically stretched ch21
1/10 Dutch AD families 10
Sleegers et al. Brain 2006
17
APP promoter mutations
  • Genetic variants that increase APP expression
  • Level of APP expression influences onset age
  • APP promoter mutations increasing levels by near
    2-fold, like in APP duplications, mimic inherited
    forms of AD

Theuns et al. AJHG 2006
18
Amyloid Cascade Revisited
AD
19
Pathology of FTD
  • Frontal and anterio-temporale cortex atrophy
  • Neuronal loss, gliosis, spongiosis
  • Histopathology

FTD
FTD with ubiquitin positive inclusions FTDU
FTD lacking distinctive histopathology DLDH
Tau positive FTD (Pick bodies NFT) tauopathy
36 50
18 22
26 48
20
Genetics of FTD
  • Familial FTD 38 50, majority autosomal
    dominant
  • 3 loci ch 17, ch 3, ch 9
  • Microtubule Associated Protein Tau
  • MAPT
  • 17q21
  • 10 43 familial FTD
  • tau-positive inclusions
  • Majority has no tauopathy and
    no MAPT mutation

21
MAPT mutations in FTDP-17
  • Missense mutations
  • in exon 1, 9, 10, 12 and 13
  • mainly affecting microtubule binding domains
  • Splice site mutations
  • in intron 3 of exon 10
  • enhances exon 10 splicing
  • results in abnormal preponderance of 4- over
    3-repeat tau

22
AD FTD spectrum
  • Alzheimers disease
  • Amyloid Precursor Protein (APP)
  • Presenilin 1 (PS1)
  • Presenilin 2 (PS2)
  • Apolipoprotein E (APOE)
  • Prion Protein (PRNP)
  • Microtubule Associated Protein Tau (MAPT)
  • Frontotemporal dementia
  • Microtubule Associated Protein Tau (MAPT)
  • Presenilin 1 (PSEN1)
  • FTDU (VCP, ?)

23
Novel PS1 G183V in classical Picks disease
Dermaut et al. Ann Neurol 2004
24
Tau-negative, Ubiquitin-positive Frontotemporal
Dementia
  • Chromosome 17q21 linked FTDU without MAPT
    mutations or FTDU-17

Cat-eye shaped
Globular shaped
Pirici, Kumar-Singh et al JNEN 2006
25
Overlapping Proteopathies
Dermaut et al. TIG 2005
26
Acknowledgements
  • Scientists
  • Marc Cruts
  • Samir Kumar-Singh
  • Jessie Theuns
  • Roos Rademakers
  • Kristel Sleegers
  • Veerle Bogaerts
  • Bianca Van Broeck
  • Julie van der Zee
  • Daniel Pirici
  • Ilse Gijselinck
  • Nathalie Brouwers
  • Hans Wils
  • Karen Nuytemans
  • Technicians
  • Marleen Van den Broeck
  • Ellen Corsmit
  • Tim De Pooter
  • Kristl Vennekens
  • Ivy Cuyt
  • Sally Serneels
  • Kenan Kamali
  • Research nurses
  • Karin Peeters
  • Mie Mattheijssens

Christine Van Broeckhoven
Write a Comment
User Comments (0)
About PowerShow.com